Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-26Clinical Trial Update: Self-Efficacy Enhancing Interviewing Techniques Study [NA]
A completed clinical trial from the University of California, Davis evaluating self-efficacy–enhancing interviewing techniques in patients w…
-
CLINICAL_TRIALS trial_result · 2008-03-24Clinical Trial Update: This Study Compared an in Home Asthma Management Program Provided by Nurses or Respiratory Therapist [NA]
A completed clinical trial compared an in-home asthma management program delivered by nurses to one delivered by a respiratory therapist.
-
CLINICAL_TRIALS trial_result · 2008-03-21Clinical Trial Update: Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma Patients [Phase 2]
Phase 2 trial evaluating pulmonary function, safety, and pharmacokinetics of zileuton injection in asthma patients has completed.
-
FDA approval · 2008-03-20FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) submitted by GlaxoSmithKline, u…
-
FDA approval · 2008-03-20FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) submitted by GlaxoSmithKline LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-14Clinical Trial Update: Efficacy Study of Herbal Formula CUF2 to Treat Childhood Asthma [Phase 1, Phase 2]
The document reports the completion of Phase 1 and Phase 2 trials evaluating the efficacy of the herbal formula CUF2 for childhood asthma.
-
FDA approval · 2008-03-07FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) by Organon LLC, updating the product labeling.
-
FDA approval · 2008-03-07FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved Organon LLC's supplemental application for Singulair (montelukast), leading to updated labeling for the product. This actio…
-
FDA approval · 2008-03-07FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) by Organon LLC. The action updates labeling under NDA020829.
-
CLINICAL_TRIALS trial_result · 2008-03-06Clinical Trial Update: The Analysis of BMI, Asthma Prevalence, and Lung Functions of Schoolchildren in Southern Taiwan
A completed clinical trial analyzing body mass index, asthma prevalence, and lung function among schoolchildren in Southern Taiwan.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma [Phase 2]
Phase II efficacy study of an aerosolized recombinant human IL-4 receptor for asthma has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: T Cell Cytokine Changes During IL-4 Receptor Treatment for Asthma
Document reports results from a completed clinical trial evaluating how IL-4 receptor–targeted therapy changes T cell cytokine production in…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Mechanisms of Allergen Immunotherapy
NIAID-sponsored clinical trial investigating the mechanisms of allergen immunotherapy in asthma and hypersensitivity has completed.
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography
Clinical trial update describing an assessment of lung inflammation in patients with atopic asthma using positron emission tomography.
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Factors Involved in Asthma and Airway Inflammation
This clinical trial update covers factors involved in asthma and airway inflammation from an NHLBI-sponsored study that has completed.
-
CLINICAL_TRIALS research · 2008-03-03Clinical Trial Update: Non Invasive Ventilation in Acute Asthma [Phase 3]
A Phase 3 clinical trial evaluating non-invasive ventilation for acute asthma conducted in Chandigarh, India; the current status is listed a…
-
CLINICAL_TRIALS trial_result · 2008-02-27Clinical Trial Update: Short- and Long Term Growth in Children With Asthma [Phase 4]
A Phase 4 trial evaluating short- and long-term growth in children with asthma has completed.
-
FDA approval · 2008-02-26FDA Approved: ASMANEX — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ASMANEX (mometasone furoate) submitted by Organon LLC to update the product labeling. The action…
-
FDA approval · 2008-02-05FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for XOPENEX HFA (levalbuterol tartrate) from Lupin Pharmaceuticals, Inc.
-
FDA approval · 2008-02-01FDA Approved: ASMANEX — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ASMANEX (mometasone furoate) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2008-01-23Clinical Trial Update: The Correlation Between Airway Inflammation and Loss of Deep Inhalation Bronchoprotection in Asthmatics [NA]
A completed clinical trial evaluating the relationship between airway inflammation and loss of bronchoprotective response from deep inhalati…
-
CLINICAL_TRIALS research · 2008-01-23Clinical Trial Update: Airway Responses to Montelukast and Desloratadine. [NA]
A completed University of Saskatchewan trial examined airway responses to montelukast and desloratadine in people with asthma.
-
CLINICAL_TRIALS research · 2008-01-17Clinical Trial Update: Inflammatory, Functional and Image Composite Measure to Define Asthma Control [Phase 4]
This is a Phase 4 clinical trial update evaluating an inflammatory, functional, and image-based composite measure to define asthma control.
-
CLINICAL_TRIALS trial_result · 2008-01-16Clinical Trial Update: Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma [NA]
Terminated clinical trial evaluating an immunotoxin on activated human macrophages in individuals with allergic rhinitis or mild intermitten…
-
CLINICAL_TRIALS trial_result · 2008-01-14Clinical Trial Update: SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults [Phase 3]
This update notes the completion of a Phase 3 trial evaluating Symbicort (budesonide/formoterol) for persistent asthma in adolescents and ad…